BIOHK2022: Hong Kong needs a more integrated and harmonised ecosystem to become a biotech fundraising hub, panellists say

December 15, 2022 Chin@Strategy

From left, Bin Li of Lake Bleu Capital, Vijay Karwal of AffaMed Therapeutics, Donald Lung, CFO of Antengene and Yinxiang Wang, chairman and CEO of Jacobio Pharma, take part in a panel discussion on ‘Capital Market for Healthcare Post Pandemic’ at BIOHK2022 on Thursday. Photo: Handout

South China Morning Post

Related posts

• 

  August 23, 2025 Media Library 0

  China’s path to military supremacy runs through an industrial powerhouse

  China is on a mission to turn its military into a modern fighting force. In the...
• August 23, 2025 Media Library 0

  Kmart supply chains under scrutiny for potential Uyghur forced labour links in Australian court case

  The letter was effusively polite, the allegations anything but. “We have the honour to address you,”...

• 

  August 23, 2025 Media Library 0

  China’s Fujian carrier may join service next month, CCTV video suggests

  China’s third and most advanced aircraft carrier, the Fujian, could be officially commissioned as early as...